MedX (შპს მედX) — Georgia Financials

panel 2026-09-21Ask

as filed · GEL, thousands

Line item	2019	2020	2021	2022	2023	2024	CAGR
	492	416	449	513	457	494	+0.1%
Total COGS	72	51	313	45	84	39	-11.8%
Gross Profit	420	366	136	467	373	455	+1.6%
Gross Margin	85.3%	87.8%	30.3%	91.1%	81.6%	92.2%
	277	301	309	433	400	385	+6.8%
EBITDA	142	65	173	35	27	70	-13.3%
EBITDA Margin	28.9%	15.6%	38.5%	6.8%	5.8%	14.2%
Total D&A	0	0	0	99	54	57	-24.1%
EBIT / Operating Income	142	65	173	64	80	13	-38.2%
Total Interest Expense	45	66	67	60	74	78	+11.6%
	14	7	52	22	34	12	-3.8%
Profit Before Tax	111	5	187	102	120	53	nmf
Total Income Tax	0	0	0	0	0	0
Net Profit / (Loss)	111	22	187	102	120	53	nmf
Net Margin	22.6%	5.2%	41.8%	19.9%	26.3%	10.8%

MedX